Mustafa Alperen Tunç

12PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors.

|Aug 27, 2026
Stage-Specific Prognostic Impact of Longitudinal Body Composition Changes in Patients with Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX: A Dual-Cohort Study.

|Jul 15, 2026
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

|May 23, 2026
Development and internal validation of the CLIP-M score for advanced mucosal malignant melanoma: exploratory prognostic stratification and comparative assessment with the RMH score.

|Jan 28, 2026
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma.

Burak Paçacı, Erkam Kocaaslan, Ahmet Demirel

|Jan 28, 2026
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

Pageof 2

Frequent Collaborators

11 joint publications

Ali Kaan Güren

10 joint publications

İbrahim Vedat Bayoğu

9 joint publications

Murat Sarı

8 joint publications

Nadiye Sever